Rezultati - Takuji Okusaka

Refine Results
  1. 1
    Immunotherapy for hepatocellular carcinoma: current status and future perspectives

    Immunotherapy for hepatocellular carcinoma: current status and future perspectives od Takuji Okusaka, Masafumi Ikeda

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines od Takuji Okusaka, Junji Furuse

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Phase II study of S-1 in patients with advanced biliary tract cancer

    Phase II study of S-1 in patients with advanced biliary tract cancer od Hideki Ueno, Takuji Okusaka, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions? od Masanori Mori, Chikako Shimizu, Asao Ogawa, Takuji Okusaka, Saran Yoshida, Tatsuya Morita

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Chemotherapy for hepatocellular carcinoma: current status and future perspectives

    Chemotherapy for hepatocellular carcinoma: current status and future perspectives od Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Izdano 2017
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    New developments in systemic therapy for advanced biliary tract cancer

    New developments in systemic therapy for advanced biliary tract cancer od Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Izdano 2018
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) od Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, Hiroshi Katayama, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses od Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, Hiromitsu Kumada

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma od Shunsuke Kondo, Hideki Ueno, Hiroko Hosoi, Junichiro Hashimoto, Chigusa Morizane, Fumiaki Koizumi, Kenji Tamura, Takuji Okusaka

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer od Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, Tatsuya Ioka, Junji Furuse, Shinichi Ohkawa, Hiroyuki Isayama, Narikazu Boku

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer

    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer od Shoichi Okada, Takuji Okusaka, Hiroshi Ishii, Akiko Kyogoku, Masayoshi Yoshimori, Naoko Kajimura, Ken Yamaguchi, Tadao Kakizoe

    Izdano 1998
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future od Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer od Takuji Okusaka, Yukako Ιtο, Hideki Ueno, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane, Yoshikazu Kagami, Hiroshi Ikeda

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma

    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma od Masafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, Shuichi Mitsunaga, Satoshi Kobayashi, Chigusa Morizane, Ikue Suzuki, S. Yamamoto, Junji Furuse

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials od Juan W. Valle, Junji Furuse, Mark Jitlal, Sandy Beare, Nobumasa Mizuno, Harpreet Wasan, John Bridgewater, Takuji Okusaka

    Izdano 2013
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection od Hiroshi Ishii, Shuichi Okada, Haruhiko Nose, Takuji Okusaka, Masayoshi Yoshimori, Tadatoshi Takayama, T Kosuge, Susumu Yamasaki, Michiie Sakamoto, S Hirohashi

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) od Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society

    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society od Takuji Okusaka, Satoaki Nakamura, Masahiro Yoshida, Masayuki Kitano, Katsuhiko Uesaka, Yoshinori Ito, Junji Furuse, Keiji Hanada, Kazuichi Okazaki

    Izdano 2020
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 od Hiroshi Ishii, J. Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, S. Ohkawa, Akira Fukutomi, Yasuo Hamamoto, K. Nakamura, Hiroyuki Fukuda

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies

    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies od Tal Grenader, Stephen Nash, Yevgeni Plotkin, Junji Furuse, Nobumasa Mizuno, Takuji Okusaka, Harpreet Wasan, Juan W. Valle, John Bridgewater

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: